The Board granted service connection for skin cancer, finding it is at least as likely as not related to the Veteran's in-service exposure to herbicide agents.
The deciding factor: The private dermatologist's opinion provided sufficient evidence to establish a causal relationship between the Veteran's skin cancer and his in-service herbicide agent exposure.
- Claimed conditions
- skin cancer
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- 100%
- Decision date
- March 25, 2025
- Citation
- A25027208
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The appeal for service connection for skin cancer was dismissed due to untimeliness, while the claim for squamous cell carcinoma was granted.
- Dismissed
The appeal was dismissed due to the Veteran's death during the pendency of the claims.
- Denied
The Board denied service connection for skin cancer, including as due to participation in toxic exposure risk activity (TERA), finding no evidence of the disease during service or within a year after separation and noting that the earliest diagnosis was nearly 25 years post-service.
- Partly granted
The Board denied service connection for colon cancer, skin cancer, and prostate cancer. The Veteran was granted a 20% rating for right knee osteoarthritis status post meniscectomy with instability or subluxation and a 10% rating for a right knee scar.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.